Interní Med. 2009; 11(12): 561-568

Nutrition and secondary osteoporosis

MUDr.Petr Fojtík1, MUDr.Ondřej Urban1, MUDr.Přemysl Falt1, MUDr.Pavel Novosad2
1 Centrum péče o zažívací trakt, Vítkovická nemocnice, a. s., Ostrava
2 Mediekos a. s., Osteologické centrum, Zlín

Nutrition has a significant impact on bone health throughout life. Proper nutritional status is essential for bone mass growth in

childhood and adolescence. Moreover, it is necessary for maintaining the bone mass during the life. An adequate intake of calcium,

vitamin D and vitamin K is essential in the treatment of osteoporosis. Recently, the positive effect of vitamin K2 on osteokalcin has

been discovered. Additionally, the impact of proteins, omega 3 fatty acids, vitamins and other trace elements on bone metabolism

has been conformed. Secondary osteoporosis is more frequent than expected, with the prevalence of 30–60 % in men and 50 % in

perimenopausal women. The most frequent postmenopausal osteoporosis might be combined with secondary osteoporosis and

diagnosing and treating these patients might be challenging. Main cause of secondary osteoporosis are gastrointestinal diseases

such as inflammatory bowel diseases (Crohn´s disease, ulcerative colitis), coeliac disease, chronic cholestatic liver diseases, patients

after gastric and intestinal surgery, pancreatic exocrine insufficiency, lactose intolerance and glucocorticosteroids treatment. Patients

with osteoporosis are usually treated by osteologists, patients with gastrointestinal diseases by gastroenterologists. Since these

patients have both osteoporosis and digestive disease the collaboration between gastroenterologists and osteologists is necessary

to diagnose and treat these patients properly.

Keywords: nutrition, osteoporosis, secondary osteoporosis, coeliac disease, lactose intolerance, vitamin K2

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fojtík P, Urban O, Falt P, Novosad P. Nutrition and secondary osteoporosis. Interní Med. 2009;11(12):561-568.
Download citation

References

  1. Alan T, et al. WGO-OMEG Practice Guideline, Osteoporosis and gastrointestinal diseases; 2004, www.omge.org/globalguidelines.htm.
  2. Bernstein Ch, Leslie W. American Gastroenterological Association medical position statement: Guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003; 124: 791-794. Go to original source...
  3. Bernstein Ch, Leslie W, et al. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003; 124: 795-841. Go to original source... Go to PubMed...
  4. Genuis S, Schwalfenberg G. Picking a bone with contemporary osteoporosis management: Nutrient strategies to enhance skeletal integrity. Clinical Nutrition 2007; 26: 193-207. Go to original source... Go to PubMed...
  5. Blahoš J. Vitamin D a choroby kostí. Postgrad Med, 2009; 11 (1): 76-78.
  6. Adams J, Pepping J, et al. Vitamin K int the treatment and prevention of osteoporosis and arterial calcification. Am J Healt-Syst Pharm-2005; 62: 1574-1581. Go to original source... Go to PubMed...
  7. Nieves J. Osteoporosis. The role of micronutrients. Clinical Nutrion 2004; (Supl.1): 142-153 WGO-OMGE Practise Guideline: Malabsorption.www.omge.org/globalguidelines.htm
  8. National Institutes of Health Osteoporosis and Related Bone Diseases - National Resource Center, Secondary Osteoporosis, 2001: 4 (1).
  9. Bureš. Metabolická kostní nemoc u chorob gastrointestinálního traktu. Postgrad Med, 2009; 11 (1): 76-78.
  10. Lafage-Proust MH, Boudignon B, Thomas T. Glucocortidoid-induced osteoporosis: pathophysiological data and recent treatments. Joint Bone Spine, 2003; 70: 109-118. Go to original source... Go to PubMed...
  11. Palička V, Živný P. Glukokortikoidy indukovaná osteoporosa. Remedia, 2007; 17: 448-450.
  12. Růžičková O, Bayer M, Pavelka K, Palička V. Doporučení pro prevenci a léčbu glukokortikoidy indukované osteoporózy u pacientů s revmatickým onemocněním. Osteol Bull, 2004; 9: 78-85.
  13. Shin HH, Kim SJ, et al. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells. Bone 2006; 39: 716-723. Go to original source... Go to PubMed...
  14. Lichtenstein R, Abreu T, Cohen R, Tremaine W. American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease. Gastroenterology 2006: 130 (3). Go to original source... Go to PubMed...
  15. Palička V. Celiakie a osteoporóza - je vazba natolik těsná, že vyžaduje akci? Vnitř Lék, 2007; 53: 1243-1244. Go to PubMed...
  16. Stenson WF, Newberry R, Lorenz R, et al. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med, 2005; 165: 393-399. Go to original source... Go to PubMed...
  17. Blahoš J. Vztah mezi osteoporózou a celiakií - editorial. Vnitř Lék, 2007; 53: 1241-1242. Go to PubMed...
  18. Kubincová Ľ, Payer J, Killinger Z, et al. Celiakia - častá príčina, ,idiopatickej osteoporózy" premenopauzálnych a včasně postmenopauzálnych žien. Vnitř Lék, 2007; 53: 1296-1302. Go to PubMed...
  19. Bischoff S, Crowe S. Gastrointestinal food allergy: New insights into pathophysiology and clinical perspectives. Gastroenterology 2005; 128: 1-36. Go to original source... Go to PubMed...
  20. Sampson HA, Sichere SH. AGA technical review on the evaluation of food allergy ingastrointestinal disorders. Gastroenterology 2001; 120: 10026-1040. Go to original source... Go to PubMed...
  21. Di Stefano M. Lactose malabsorption and intolerance and peak bone mass. Gastroenterology 2002; 122: 1793-1799. Go to original source... Go to PubMed...
  22. Lewis N, Scott B. Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease. 2007; BSG Guidlines in Gastroenterology; www.bsg.org.uk.
  23. Leslie W, Bernstein Ch. AGA technical rewiew on osteporosis in hepatic disorders. Gastroenterology 2003; 125 (3): 1-41. Go to original source... Go to PubMed...
  24. Lipkin EW. Metabolic bone disease in gut diseases. Gastroenterol Clin N Am, 1998; 27: 513-523. Go to original source... Go to PubMed...
  25. Palička V. Žaludek a metabolismus kostní tkáně. Vnitř Lék, 2003; 49: 166-167. Go to PubMed...
  26. Payer J, Šteňová E, Killinger Z, et al. Metabolické zmeny u pacientov po parciálnej resekcii žalúdka. Vnitř Lék, 2003; 49: 194-199. Go to PubMed...
  27. Mun EC, Tavakkolizadeh A. Complications of bariatric surgery. UpToDate, vol 16.2. Welleysley, 2008. www.uptodate.com




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.